한국어
English
日本語
中文(简体)
Glyfen Sustained Release Capsule (Fenofibrate Pellet)
337.64mg
Prescription medication
Samchundang Pharmaceutical Co., Ltd.
Fenofibrate pellets are ingredients used to improve blood lipids and are utilized in the treatment of atherosclerosis.
MFDS ingredient code M095127
Fenofibrate pellets are a medication used for blood lipid control, primarily in the treatment of hyperlipidemia. This ingredient belongs to the fibrate class and aims to lower blood triglyceride and bad cholesterol levels.
Fenofibrate pellets promote lipid metabolism in the liver, helping to break down triglycerides and lower bad cholesterol (LDL) levels. This reduces the accumulation of fat in blood vessels, slowing the progression of atherosclerosis.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other lipid-lowering agents, fenofibrate is primarily effective in reducing triglycerides and is specialized in maintaining blood lipid balance along with cholesterol control.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.